Next Financial Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Next Financial Group’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$2K	Hold	750	–	–	﹤0.01%	2675
2021 Q3	$3K	Hold	750	–	–	﹤0.01%	2430
2021 Q2	$4K	Hold	750	–	–	﹤0.01%	2289
2021 Q1	$5K	Hold	750	–	–	﹤0.01%	2132
2020 Q4	$4K	Hold	750	–	–	﹤0.01%	2061
2020 Q3	$4K	Buy	+750	New	+$4.49K	﹤0.01%	1938
2020 Q2	–	Sell	-600	Closed	-$4K	–	2039
2020 Q1	$4K	Buy	600 +50	+9%	+$401	﹤0.01%	1799
2019 Q4	$6K	Buy	+550	New	+$4K	﹤0.01%	1942
2019 Q1	–	Sell	-86	Closed	-$2K	–	2200
2018 Q4	$2K	Sell	86 -114	-57%	-$2.33K	﹤0.01%	1786
2018 Q3	$6K	Buy	+200	New	+$7.74K	﹤0.01%	1146

Other funds holding CLVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Next Financial Group's CLVS Position: Q4 2021 in Review

Next Financial Group held its Clovis Oncology, Inc. (CLVS) position steady in Q4 2021 at 750 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2675.

Next Financial Group first reported a position in CLVS in Q3 2018 and has held it in 10 quarters since. The position peaked at $6K in Q4 2019. 153 funds tracked by Wall St. Rank hold CLVS as of Q4 2021.

Next Financial Group held 750 shares of Clovis Oncology, Inc. worth $2K as of Q4 2021.
Next Financial Group left its Clovis Oncology, Inc. share count unchanged in Q4 2021.
Clovis Oncology, Inc. made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2675 holding.
Next Financial Group first reported a position in Clovis Oncology, Inc. in Q3 2018 and has held it in 10 quarters since.
Next Financial Group's Clovis Oncology, Inc. position peaked at $6K in Q4 2019.
153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.